Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
— CAPTUREOfficial title:
The CAPTURE Study: Validating a Unique Chronic Obstructive Pulmonary Disease (COPD) Case Finding Tool in Primary Care
Verified date | July 2022 |
Source | Weill Medical College of Cornell University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is a qualitative research exploration engaging clinical staff at all levels from 10 Practice-Based Research Networks (PBRNs) serving US patient populations of differing gender, racial, ethnic, urban/rural and socio-economic blends, in the incorporation of a one-page, five-item questionnaire with selective PEF measurement (CAPTURE).
Status | Completed |
Enrollment | 196 |
Est. completion date | April 1, 2022 |
Est. primary completion date | April 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: Clinician Participants: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with availability and all study procedures for the duration of the study by the 10 practices (through PBRN recruitment) and their up to 15 clinicians within (through informed consent). 3. Male or female, aged 45 - 80 years Patient participants [200 participants enrolled in Aim 1 of the CAPTURE Study for an opinion survey]: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Male or female, aged 45 - 80 years. Exclusion Criteria: 1. Clinician participants: current employment at practices participating in aims 1 and/or 3 2. Clinician participants: from practices providing fewer than 2 clinician participants 3. Patient participants: meeting the exclusion criteria for aims 1 and 3 (above) |
Country | Name | City | State |
---|---|---|---|
United States | High Plains Research Network | Aurora | Colorado |
United States | Atrium Healthcare | Charlotte | North Carolina |
United States | Duke University | Durham | North Carolina |
United States | LANet | Los Angeles | California |
United States | COPD Foundation | Miami | Florida |
United States | Oregon Rural Practice-based Research Network (ORPRN) | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Weill Medical College of Cornell University | COPD Foundation, Duke University, High Plains Research Network, L.A. Net Community Health Resource Network, National Heart, Lung, and Blood Institute (NHLBI), National Jewish Health, Oregon Health and Science University, University of Kentucky, University of Michigan, University of Minnesota, Wake Forest University Health Sciences |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary care clinician perspective on implementing CAPTURE into primary care practice. | Primary care clinician perspective on implementing CAPTURE will be assessed using the RE-AIM approach in two focus group sessions consisting of clinical staff self-reporting current clinical practices, the process for implementing a new tool into practice and review of the CAPTURE tool. | Baseline to 2 years | |
Secondary | Primary care clinician knowledge about respiratory care at the provider level. | Primary care clinician knowledge will be assessed using a questionnaire to self report about knowledge and beliefs regard Chronic Obstructive Pulmonary Disease (COPD) and COPD management. | Baseline to 2 years | |
Secondary | Primary care clinician knowledge about respiratory care at the provider level. | Primary care clinician knowledge will be assessed using two focus groups to self report on the staff's knowledge regarding respiratory care. | Baseline to 2 years | |
Secondary | Primary care clinician attitudes and beliefs regarding respiratory care and communication within their current practice. | Primary care clinician attitudes and beliefs will be assessed using a questionnaire to self report respiratory care in their current practice. | Baseline to 2 years | |
Secondary | Primary care clinician self-efficacy in provider-specific respiratory clinical care. | Primary care clinician self-efficacy will be assessed using two focus groups to self report on the staff's perspective regarding self-efficacy of provider-specific respiratory practices. | Baseline to 2 years | |
Secondary | Primary care clinician attitudes and beliefs about clinical quality improvement and communication within their current practice. | Primary care clinician attitudes and beliefs regarding quality improvement and communication within their current practice will be assessed using two focus groups to self report attitude and beliefs. | Baseline to 2 years | |
Secondary | Existing COPD Clinical care operations within a variety of primary care practices. | COPD clinical care operations at various practices will be assessed using two focus groups to self report current COPD clinical care operations within primary care clinicians own practices. | Baseline to 2 years | |
Secondary | Existing COPD Clinical care operations within a variety of primary care practices. | Details of COPD clinical care operations at various practices will be assessed using a questionnaire to self report current COPD clinical care operations within primary care clinicians own practices. | Baseline to 2 years | |
Secondary | Primary care clinician attitudes and beliefs about screening and diagnostic assessment strategies of respiratory care and communication within their current practice. | Primary care clinician attitudes and beliefs regarding screening and diagnostic assessment strategies and communication within their current practice will be assessed using two focus groups to self report attitude and beliefs. | Baseline to 2 years | |
Secondary | Primary care clinician attitudes and beliefs about screening and diagnostic assessment strategies of respiratory care and communication within their current practice. | Primary care clinician attitudes and beliefs regarding screening and diagnostic assessment strategies and communication within their current practice will be assessed using a prescriber questionnaire to self report attitude and beliefs. | Baseline to 2 years | |
Secondary | Patient comprehension of CAPTURE tool instructions and questions. | Patient comprehension of CAPTURE tool instructions and questions will be assessed using a CAPTURE opinion survey to self report comprehension. | Baseline to 2 years | |
Secondary | Patient ease of completion of the CAPTURE tool. | Patients' ease of completion of the CAPTURE tool will be assessed using a CAPTURE opinion survey to self report ease of completion. | Baseline to 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03282019 -
Study of Long-term HFNC for COPD Patients With HOT
|
N/A | |
Completed |
NCT05573464 -
A Study to Assess the Safety of Budesonide/Glycopyrronium/Formoterol Fumarate With the Hydrofluoroolefin Propellant in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
Recruiting |
NCT06040086 -
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
|
Phase 3 | |
Not yet recruiting |
NCT06376994 -
Multi-Center Clean Air Randomized Controlled Trial in COPD
|
Phase 3 | |
Completed |
NCT02926534 -
Cross-Sectional Study of COPD Prevalence Among Smokers, Ex-smokers and Never-Smokers in Almaty, Kazakhstan
|
N/A | |
Completed |
NCT02797392 -
Feasibility of a Preventive Program Against Lifestyle Related Diseases
|
N/A | |
Completed |
NCT02728674 -
Management of Patients With Respiratory Symptoms in Sweden
|
N/A | |
Recruiting |
NCT02415478 -
Bronchioscopic Lung Volume Reduction (BLVR)
|
N/A | |
Completed |
NCT02774226 -
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02459080 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02512510 -
Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT02518139 -
A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03487406 -
Anti-platelet Therapy in the Prevention of Cardiovascular Disease in Patients With COPD (APPLE-COPD: ICON 2)
|
Phase 2 | |
Completed |
NCT01908140 -
Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01615484 -
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
|
N/A | |
Completed |
NCT01893476 -
A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management
|
N/A | |
Withdrawn |
NCT01908933 -
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
|
Phase 3 | |
Completed |
NCT01701869 -
Microbiology & Immunology of the Chronically-inflamed Airway
|
N/A | |
Recruiting |
NCT02527486 -
Seoul National University Airway Registry
|
N/A | |
Withdrawn |
NCT01377428 -
Efficacy of Indacaterol 150 µg Versus Formoterol
|
Phase 4 |